ML20098B177
| ML20098B177 | |
| Person / Time | |
|---|---|
| Site: | Arkansas Nuclear  |
| Issue date: | 08/17/1984 |
| From: | James M. Levine ARKANSAS POWER & LIGHT CO. |
| To: | NRC |
| References | |
| PROC-840817, NUDOCS 8409250456 | |
| Download: ML20098B177 (25) | |
Text
.
m ARKANSAS POWER & LIGHT COMPANY
]
Arkansas Nuclear One Mt.E: TRANSMITTAL FORM NO. 1013.02H REV. # 20 PC #
Arkansas Nuclear One Russellville, Arkansas Date 8/17/84 MEMORANDUM
}OhNk WM TO:
RETURN T0:
ARKANSAS NUCLEAR ONE Document Control FROM:
ANO DOCUMENT C01; TROL Admin. Bldg. - 4th Floor
SUBJECT:
ANO MASTER PLANT MANUAL UPDATE PROCEDURE NUMBER 1903.35 REV; #
0 PC #
TC #
PROCEDURE TITLE ADMINISTRATION OF POTASSIUM IODIDE PROCEDUPI NUMBER 1903.42 REV. #
6 PC #
TC #
PROCEDUPI TITLE DUTIES OF THE EMERGENCY MEDICAL TEAM L
PROCEDURE NUMBER REV. #
PC #
TC #
PROCEDURE TITLE The following pages of the indicated procedure (s) contains items which involve personal privacy or proprietary material. PLEASE PIMOVE THE INDICATED MATERIAL PRIOR TO DISTRIBIIIION TO PUBLIC DOCUMENT ROOMS, ETC.
PROCEDURE (S)
PAGE(S)
J h/
l l PROCEDURE (S) HAS BEEN PL\\CED IN YOUR SET OF THE PLANT MANUAL.
[ROCEDURE (S) SHOULD BE PLACED IN YOUR SET OF THE P l
SIGNATURE DATE UPDATED y
g 1
8409250456 840917 C
PDR ADOCK 05000313 l
F PDR
l l
ATTENTI0N THE ATTACHED PROCEDURE 10103. 5.5 REV.
A SHOULD BE PLACED IN UNTIL EFFECTIVE DATE.
EFFECTIVE DATE 7 b PLEASE DO NOT REMOVE c. = =--=rir :r M MAL BEFORE EFFECTIVE DATE LISTED AB0VE.
J 6
-~
1 J'.'95lsARKANSAS POWER & LIGHT C r;]g-
,1 Arkansas Nuclear One m W kCORD OF CHANGES AND REVISIONS FoW No.1000.06A R
.s EMERGENCY: PLAN IMPLEMENTING PROCEDURE REV. #12 FC # /
s T.
(
l Safety Related YES d NO O 4.'.s [3
~
-)
ADMINISTRATION OF POTASSIUM IODIDE
.g 1903 35 REV. O ff 1
OSI[h $)[b
.,iVi M F IOY PA' dd 'REVbCh#
PAdd ibE.Y.3)C//
PAGE REV 'PC#
PAGE REV PC#
PAGE DEV PC// ' #
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
10 0
11 0
12 0
13 0
2 APPROVED BY:
APPROVAI. DATE j'
r? /S ff n //,.,m,_. /R 44 REQUIRED'EFFE N DATE:
(General Manager) g ] Cf, g }
fMEIM&^t&9 TION:
Pgg,ggggglTLE:
NO:
j IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 y /5 PAGE s'
'4 M
ARKANSAS NUCLEAR ONE Ta= vision l
u oars v " v"'
CHANGE DATE 1.0 PURPOSE The purpose of this procedure is to provide guidance for the administra-tion of potassium iodide (KI) to ANO and contractor employees who have been, or may be, exposed to airborne radioiodine concentrations which could result in a thyroid dose equal to or greater than 10 rads.
2.0 SCOPE This procedure applies to all ANC and contractor employees prior to a planned exposure to radiciodine and after an accidental exposure.
3.0 REFERENCES
3.1 References used in preparation of this procedure:
3.1.1 NCRP 55, Protection of the Thyroid Gland in the Event of Releases of Radioiodine 3.1.2 IAEA Technical Report No.152, Evaluation of Radiation Emergencies and Accidents 3.1.3 AP&L Management Directive ESD-83-11.
3.1.4 AP&L Memorandum, David Snellings to Tom Baker, No-83-394, dated October 14, 1983 3.2 References used in implementation of this procedure:
3.2.1 Emergency Plan 3.2.2 Procedure 1903.60, " Emergency Supplies and Equipment" 3.2.3 Patient Package Insert for Thyro-Block " (Potassium Iodide), Wallace Laboratories, dated October, 1979 3.2.4 Procedure 1622.015, " Bioassay Sampling Program" 3.2.5 Procedure 1609.003, "Use of,, Respiratory Equipment" 3.3 Related ANO procedures:
3.3.1 1000.31, " Radiation Protection Mar. cal" 3.3.2 1000.33, "ANO ALARA Manual" 3.3.3 1903.42, " Duties of the Emergency Medical Team" 3.4 Regulatory correspondence containing NRC commitments which are implemented in this procedure:
None 1
I
g(gygTION:
PgggOgglTLE:
NO:
IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 PAGE 5 N 'A ARKANSAS NUCLEAR ONE
_aevision "
oars /"'
- CHANGE DATE 4.0 DEFINITIONS None 5.0 RESPONSIBILITIES
~
1 5.1 The Duty Emergency Coordinator / Emergency Coordinator is responsible for the overall control and implementation of this procedure.
)
3 5.2 The Health Physics Superintendent is responsible for assessing pre-and post-exposure dose, for assessing the need for the administration of KI and for advising the Duty Emergency Coordinator / Emergency Coor-dinator of the need for the use of KI.
5.3 The Medical Team Leader is responsible for the administration of KI to the appropriate individuals.
6.0 INITIATING CONDITIONS The provisions of this procedure shall be invoked when either of the following conditions are met.
6.1 An individual, or individuals, is preparing to enter an area con-taminated with airborne radiciodine and he is judged by the Health Physics Superintendent to be at a significant risk of incurring a thyroid dose of equal to or greater than 10 rads.
6.2 An individual, or individuals, has been accidentally exposed to air-borne radiciodine and his (their) thyroid dose is expected to be equal to or greater than 10 rads.
I NOTE:
l l To be most effective, KI must be administered prior to l
i exposure to radiciodine.
If, for any reason, initial KI l
l administration is delayed for longer than 4 hours4.62963e-5 days <br />0.00111 hours <br />6.613757e-6 weeks <br />1.522e-6 months <br /> after l
l exposure, only limited thyroid blocking will occur.
l 7.0 PROCEDURE 2
7.1 Using Attachments 1 and 2, the Health Physics Superintendent shall determine if the projected thyroid dose will be equal to or greater than 10 rads, Document the estimate on Form A.
If the thyroid dose is projected to be less than 10 rads, proceed to Step 7.6.
l NOTE:
I l If the thyroid dose is projected to be less than 10 rads, I l KI is not to be used.
l
~
I l
m
j fhfMhgApgTION:
Pgg,ggggggplTLE:
NO:
IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 y
PAGE 3 05 Ad ARKANSAS NUCLEAR ONE mawson o*Ts **"
u CHANGE DATE i
7.2 If the projected thyroid dose is apparently greater than 10 rads but is not within the bounds of the Thyroid Dose Graph, Attachment 1, the projected dose may be calculated as follows:
Dose in Rads = 2.51 x 10' X ( S ) X Time PF Where Q = airborne iodine concentration in pCi/cc PF = respiratory equipment protection factor (Attachment 2)
Time = exposure time in minutes If this calculation is made, the results shal,1 be documented in Part A of Form A.
7.3 The Health Physics Superintendent shall notify the Duty Emergency Coordinator / Emergency Coordinator of the projected thyroid dose.
7.4 The Health Physics Superintendent should contact Millard-Henry Clinic (MHC) and inform the MHC physicians (preferably Dr. Teeter, Carter, or New) of the need to administer KI.
l NOTE:
l l The Medical Staff of MHC has previously concurred with thel l administration of KI under specified conditions. This l
l notification is for information purposes only, and adnin-l l istration of KI should not be delayed pending contact withl l MHC.
l 7.4.1 The Duty Emergency Coordinator / Emergency Coordinator shall document the Duty Emergency Coordinator / Emergency Coordin-ator's authorization for the administration of KI and the notification of the MHC physician in the Duty Emergency Coordinator / Emergency Coordinator's Log. If contact was not made earlier with a MHC physician, continue efforts to establish contact.
7.5 The Duty Emergency Coordinator / Emergency Coordinator shall instruct the Medical Team to report to the First Aid Room and prepare for KI administration.
7.5.1 The Health Physics Superintendent shall transfer a Form 1903.35A, with Part A completed for each individual to re-ceive KI, to the First Aid Room when the Medical Team is activated for KI administration.
7.5.2 The Duty Emergency Coordinator / Emergency Ccordinator shall instruct individuals who are to be offered KI to report to the First Aid Roem.
ENDE#bp{gTION:
PgrygggylTLE:
NO:
IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 I 14
_PAGE ARKANSAS NUCLEAR ONE mevision u oATE -
CHANGE DATE 7.5.3 The Medical Team Leader shall direct the individuals about to receive KI to read the Thyroid Blocking Agent Precau-tions Leaflet (Attachment 3).
7.5.4 The Medical Team Leader shall complete Part B of the Potassium Icdide Administration Form, Form A, for each individual.
7.5.5 After the individuals have read the precaution leaflet (Att. 3) and their Potassium Iodide Administration Form has been completed, they shall sign their Form A.
The Medical Team Leader shall stress to the individuals that the taking of KI is voluntary. Prior to taking the KI, the Health Physics Superintendent shall advise the indi-viduals of the projected thyroid dose, explain the protec-tion offered by the KI, and discuss the potential bio-logical effects of the projected thyroid dose following KI adninistration. If any individuals choose not to take the KI, the Medical Team Leader shall notify the Duty Emergency Coordinator / Emergency Coordinator and the Health Physics Superintendent. The Health Physics Superintendent shall advise them of the potential biological effects of the projected thyroid dose without KI protection. This action shall be noted on the individual's Form 1903.35A.
7.5.6 When each individual's Potassium Iodide Administration Form, Form 1903.35A, has been signed, each individual will be issued a KI tablet to be taken at that time.
7.5.7 Each exposed individual shall be instructed to return each morning for the next 4 consecutive days for an additional KI tablet. Daily adninistration of KI shall be documented on Form 1903.358. The initials of the Medical Team member administering the KI and the date of administration shall be noted on the form in the space provided. This step should complete Part B of Form 1903.35A.
l NOTE:
l l KI intake should continue;for four days past thel i last radioiodine exposure. However, radioicdinel I exposure must be limited such that KI is taken l l for no more than 10 consecutive days.
l I
l 7.6 Whole body counts shall be conducted in accordance with Health Phy-sics Procedure 1622.015, " Bioassay Sampling Program"; within the foi-lowing guidelines:
gggAgqTION:
PggggglTLE:
NO:
j j IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 y /4 I
U "5 'A PAGE WE ARKANSAS NUCLEAR ONE aavision "
o^te " " " ' ' ' "
CHANGE DATE 7.6.1 Individuals occupationally Exposed For individuals preparing to enter a radiciodine-contaminated area and whose projected thyroid dose is expected to be equal to or greater than 10 rads, a whole body count should be performed prior to exposure (if practical). A whole body count should be performed post-exposure as soon as practical (it is suggested that a whole body count be performed within 48 hours5.555556e-4 days <br />0.0133 hours <br />7.936508e-5 weeks <br />1.8264e-5 months <br />). Additional whole body counts should be performed at the Health Physics Superintendent's discretion consistent with the requirements of Procedure 1622.015.
7.6.2 Individuals Accidentally Exposed For individuals accidentally exposed to radioiodine, a whole body count should be performed as soon post-exposure as practical (it is suggested that a whole body count be performed within 48 hours5.555556e-4 days <br />0.0133 hours <br />7.936508e-5 weeks <br />1.8264e-5 months <br />). Additional whole body counts should be performed at the Health Physics Superintendent's discretion consistent with the requirements of Procedure 1622.015.
7.7 Additional bioassay (e.g. urinalysis and thyroid function studies) shall be performed if deemed necessary by either the MHC physician or the Health Physics Superintendent.
7.8 Forms 1903.35A and 1903.35B shall be forwarded according to the following instructions:
7.8.1 The Medical Team Leader shall turn over Forms 1903.35A and 1903.35B to the Health Physics Superintendent as they are completed.
7.8.2 The Health Physics Superintendent shall complete Part C of Form 1903.35A.
7.8.3 The Health Physics Superintendent shall assure that copies of Forms 1903.35A and 1903.35B are placed in the appropriate individual's Exposure File end that internal doses, as de-termined by Procedure 1622.015, " Bioassay Sampling Program",
are calculated and documented in each individual's Exposure File.
7.8.4 After copies of the forms are sent to the individual's Exposure File, the Health Physics Superintendent shall forward completed forms to the Duty Emergency Coordinator /
Emergency Coordinator for retention.
gghggApgTION:
PgC,ggggfiTtE:
NO:
IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 PAGE O UN N ARKANSAS NUCLEAR ONE
>< vision "
oATE ~~~
CHANGE DATE 8.0 ATTACHMENTS 8.1 Attachments 8.1.1, " Thyroid Dose Graph",
8.1.2, " Respiratory Equipment Protection Factors" 8.1.3, " Potassium Iodide Precaution Leaflet" 8.2 Forms 8.2.1 Form 1903.35A - Potassium Iodide Administration Form 8.2.2 Form 1903.35B - KI Issue Record J
1 1
..~..
M M5MMTION:
Pjgg{gygg,ggTITLE:
NO:
j IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 5
PAGE d
"M
'D W ARKANSAS NUCLEAR ONE m e==
oars """/"
CHANGE DATE ATTACHMENT 1
-00 THYROID DOSE GRAPH
_-._;___.g.
=. _. -
.z.
C,
_. J.5 :. _.. _ ;=
_z:.._
a.-.2-.
(
- _y.. ;=-
~.~..'_f~'_
-' f.. _ :.
~ ~ ~ ~ ~ -
j 3_== 5. :. _. _ _
~
_ ~:[~~.]':
l.[.'.] -
_ _. Ih.T.i::
f
- ^ ~ ~
.___-_=..__.._..~.~_=___:...-....
~ ~~~~
.. 2. ~2 ~. ' ~ :._.
3
~~~~.~~.~~,~~'._'~~'__~.:.-'.^-~.. _. _. _
'T'.T._. _ _...
~
- 00..
- - ~ ~ '
_. ~ ~
'~
..THYROI1 DOSE
<10' R'ih '-~ ~~ ---.
THYROID DOSE
. _. ~...
5
>10 Rads
_m
..__m_.
(
y
_-~L.-_..-.___....____.--_[-_.
~
E
^g
' ' ~ ' ' ~.. _. _
_~~ --
p
~. Wg 0--.____.
- g
. w
-._.______L_.
w
(
my k
10-7 10-C
~ ~ ~ ~ ~10-5 10-4 I-131 Concertration (in sci /cc)/ Protection Factor C
C k
r kMhNhpfgTION:
Pggggg,glTLE:
NO:
j l
IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 y /5 I
PAGE O
'I 14 ME ARKANSAS NUCLEAR ONE aavision u oars v " u"/ O'-
CHANGE DATE ATTACHMENT 2 RESPIRATORY EQUIPMENT PROTECTION FACTORS Equipment Gases, Vapors Air Purifying Bearing NIOSH Approvals Series TC-21C 1.
Negative Pressure Full Facepiece (includes Duo-Flo in filter mode) 1 2.
Positive Pressure Air Purifying Full Facepiece, Hood, Half Facepiece 1
Atmosphere Supplying Airline (in-cluding Duo-Flo in airline mode)
Bearing NIOSH Approval Series TC-19C 1.
Full Facepiece 2,000 2.
Half Facepiece 1,000 3.
Suit 1
4.
Hood 1,000 Atmosphere Supplying Self-Contained Breathing Apparatus Bearing NIOSH Approval Series TC-13F 1.
Pressure Demand Air Mask 10,000 2.
Recirculating Pressure-Demand 5,000 (Bio-Pak)
l j
4 gggug'ON:
PgggggTITLE:
NO:
IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 b
y PAGE S 5N
~
ARKANSAS NUCLEAR ONE asvision u oara ' ' ' " '
- CHANGE DATE ATTACHMENT 3 Page 1 of 2 e.e o.e..
e.,
THYRO BLOCK'"
(POTAssauais e00:011 iomeo aoe f aib e # E'$ M ew sp 4Goremated R4
?a8(175 aae SOLuflose W 5 P TAKE POTASSIUM IODIDE ONLY WHEN PUBLIC HEALTH OFFICI ALS TELL YOU. IN A RA DI ATION EM E RG ENCY. RADIOACTIVE !ODINE COULD BE RELEASED INTO THE AIR. PCTASSIUM lODIDE lA FORM OF IODINFJ CAN HELP PROTECT YOU.
IF YOU ARE TOLD TO TAKE THIS MEDICINE. TAKE IT ONE TIME EVERY to HOUK1 DO NOT TAKE IT STORE OFTEN. MORE WILL NOT HELP YOU AND MAY IN-CREASE THE RISK OF SIDE EFFECTS. DO NOT TAKE THIS DRfl0 IF YOU KNOW YOU ARE ALLERGIC TO IOD/DE ISEE SIDE EFFECTS BELOwJ INDICATIONS T! IRO!D BLOCKING IN A RADIATION EMERGENCY uNLY.
DIRECTIONS FOR USE Use only as directed by State or local pubhc health authernaeg in i
the event of a radiation emergency.
DOSE Tab:ets ADULTS AND CHILDREN I YEAR OF AGE OR OLDER. One tis tabset once a day. Crush for smail chaidren.
BABIES UNDER 1 YEAR OF AGE.
Onehelf Ili23 tablet once a day Crusn first.
Solutaon:
ADULTS AND CHILDREN I YEAR OF AGE OR OLDER. Add a drops to one half glass of hquad sad drtnis each say.
BABIES UNDER 1 YEAR OF AGE.
Add 3 drops to a amad amount of bquad once a day.
For ed desave /osma-Take for 10 days unless directed othee by State or local pubhc health authoritees.
Store at contron:ed room temperati re between 15' end 30"C;59' to 66*FL Keep container tashtly closed sad protect from kant.
Do not use the soeutwa if n appears brownish in the asasie us the bottle.
o WARNING Perenssem sedade skeslut ses 6e used by people auerre to eensde Keep out of the reach of chaldren. In case of peerdose or ailerec -
reaction. contact a pnysician or the pubhc health autnanty DESCRipT10N 2 Each THYRO BLOCKN TABLET contains 130 mg of potassium mdade.
A Each drop of THYRO BLOCKN SOLUT!CN conteens 21 mg of potasseum aodide k
m M%gAgTION:
PggiggglTLE:
NO:
l IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 h
PAGE AV 01 AJ ARKANSAS NUCLEAR ONE
> E-N v Dm me CHANGE DATE ATTACHMENT 3 Page 2 of 2 MOW POTASSluM 800 TOE WOftn$
Certaan farms uf todane help your thyroid stand weerk right Most people get the sudane they need from foods, hke sodated seit or fish. The Lloyraed can 'susre" or ho6d only a certain amount of sodans la e radaet.nn emergency, redaootuve widine mas be reareged en time ser l'Ns meterial mov be hrvalhed or eweile*wed it r' tat enter the th>resed gland and damage et I"he domeste mesund prte bebit not =how eaself for veers. Chddren are et likele to hase thyroid dems.c, If you take potasseum sadida it wsil fi3 up your thyred gland.
Thas reduces the chance that harmful redacecuve modine udt enter the anyroid stand.
WMO SHOULO NOT TAKE POTAS$1UM ICDICE The only peopae who should not same potasesum indede are people who know they are ellergie te todade. You may take potassium sechde even af you are tamang medicanes for a thyroid problemifor eaampse, a thyroid hormone or enuthyroid drugt. Pregnant and oursing women and babase and chJdren may mise take this drug.
HOW AND WHEN TO TAKE POTASSIUM IODICE Potassium todade should be takes as soon as poes.ble eher pubiac health offwists tell you. You should take one dose every 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br />. More odi not help you because the thyroid can " hold'* en-ly hmated amounts of sodane Larger doses edi meresse the nsk of side effects. You weil pronably be toad not to taae the drug for more than 10 days.
SIDE EFFECTS Usually, side effects of potassium iodade happen when people
(
take higher doses for a long time. You should be careful not to take more than the recommended dose or take it for longer than you are to6d. Side offacts are unkkely because of the now done and the short uma you wul be tasang the drug.
Possible sade effects teclude skin rashes. swetlang of the solavary gtands. and "modamm'* Imetadac taste. burnang mouth and throek sore teeth and gums. symptoms ei e heed cold, and someumes stomach upset and daarrhew.
A few people have en allergw reaction with more serious syml>
tems. These could be fewer and joant pains, or sweding of parts of the face end body and at umes severe shortness of breath requar-mg unmedaate medacal attenuon.
Takans sodade may rarely cause overecuvity of the thyroid gland, underacuvity of the thyrood stand or eniargement of the thyroid gland Igoiters.
WM 4T TO 00 IF S30E EFFECTS OCCUR If the side effects are severe or af you have an allergic rescuen.
stop tasans pos.essium iodade. Then, af poseable, can a doctor or pubhc heash authority for instrucuent MOW StiPPLIED THYROBLOCKN TABLETS iPotassium todade. U.S Pi bot-Lies of Ie tablets INDC 00374e72-20.t Each whata, round. scored tabiet contaar.s 130 mg potassium iodade.
THYROBLOCKN SOLUTION iPotassium todade Soluuon.
U.S.PJ 30 mill fL wJ hght-resistant meesbred-dre 3 dispensuis umts (NDC 0037-4287-2SL Each drop contaans 21 erg potesesum nodade.
- ' j waLLACE LA80matonfES A..
C.wisce of CAntt$ Wa(LACE INC Csaceury. New deesev G8Si2 CW.50F9,5 o0rF9 issue 10r19 C '2.1 A
E r
i M
MgggTION:
gygggTITLE:
NO:
i f
IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35
[.
PAGE AA "N AJ ARKANSAS NUCLEAR ONE Tasvision u
oare v"""'"*
CHANGE DATE ARKANSAS POWER & LIGHT COMPANY Arkansas Nuclear One
" % m m its mirne wwfvisTRATION FORM l '0" "0 1903. 35 A REV. # 0 PC #
- - _ _ -- _ --, _ _ - _ -- -- _ ;; _ _ - _ -- ;;; - - ;; ; -- - ;;;;; ;;;- _ - _ _ ;;;; - - - ;; _ - - ; ge 1 o f 2 Pa PART A Name of Exposed Individual Last Middie First Social Security Number _-
TLD Badge Number Projected / Actual Estimated Duration of Exposure Minutes I M' Concentration pCi/cc in Air Respiratory Protection Worn During Exposure? Yes _ No _
If "Tes", Respiratory Equipment Protection Tactor (Attachment 2) =
If "No, explain why i
Projected Thyroid Dose from Thyroid Dose Graph
> 10 RAD or
< 10 RAD (Check One)
/
Health,PhysicsSupertntendent Date CT Date of Exposure Time of Exposure If calculated, projected thyroid dose (per paragraph 7.2) =
Rads
/
klealth Phystes Supertntendent Date
- - - _, _ - - _ _, ; n _, -, rw, ; - _ ; ;., -
n---
- i. ---_- _ -
R /. - ; l^N I
b.,
LD N
4-
e I
yggygTION:
Pggg g gg g g iTLE:
NO:
IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 PAGE
" "N "
ARKANSAS NUCLEAR ONE
-aevisioN u
oarE v ' / u a -
l CHANGE DATE y
ARKANSAS POWER & LIGHT COMPANY
[c Arkansas Nuclear One
%TASSif*1 inDICE ADMINISTRATION FORM l FON NO.1903.35A REV. 8 PC #
Page 2 of 2 PART B Known Iodide Allergy / Previous Allergic Reaction? Yes No Unknown If "Yes", do not administer KI.
If " Unknown", contact the Health Physics Superintendent and/or the Duty Emergency Coordinator / Emergency Coordinator for further guidance.
I verify that I have read and understand the precaution leaflet and I understand that taking thyroid blocking agent (i.e., KI) is strictly voluntary.
I do do not (check one) choose to take KI.
/
/
Exposed Individual Date Time Potassium Iodide Tablet Issued By (and arrangements made to administer KI for the next 4 consecutive days per Section 7.5.7):
/
/
Medical Team Leader Date Time NOTES:
o A -
- .--.----,.-----,..:---------------nevir*w* Mar *****
PART C i have reviewed the above information.
/
Health Physics Superantendent Date J
c= v :,
C E
N r
f
=
M
&.N5mygTION:
Pg{gygggTITLE:
NO:
- j IMPLEMENTING PROC.
POTASSIUM IODIDE 1903.35 O
PAGE N WE N ME ARKANSAS NUCLEAR ONE aEvision U DATE vv*'a' CHANGE DATE ARKANSAS POWER & LIGHT COMPANY A'rkansas Nuclear One "E, v een l FOW Na
,31_ p q i
- e. f. men 9
RIV. 80 PC #
Exposed Individual's Name Social Security Number TLD Projected / Actual Exposure Date of Exposure i
Dose i
Dosage i
Date i Inttials of Medical Team i I Number ] (millierams) l Administered i Member Administerine Dose I I
i l
i i
it i
I I
I I
i i
i i
12 I
I I
I I
I I
I I
I1 1
I I
I I
I I
I I
I4 I
I I
I I
I i
i i
15 I
I I
I I
I I
I I
l6 I
I I
I I
I I
I I
i7 I
I I
I I
i i
l i
I8 1_
l i
I I
I I
I I
I9 I
I I
I I
i i
l i
e i 10 l
I i
C
~
A.
i C
~
c LN
m.,,
- - - ~
v--,---
s 9
g 6
T-t T
ATTENTI0N THE ATTACHED PROCEDURE 190370 REV.
20 SHOULD BE PLACED IN FRONT OF CURRENT PROCEDURE UNTIL EFFECTIVE DATE.
9 EFFEbTIV.EDATE9 - 2 C1 - M PLEASEDONdTREMOVECURRENTREVISION 5I BEFORE EFFECTIVE DATE LISTED AB0VE.
.~
k A
Mr t
, i s
. s
% - i e
J 5
.\\ -
l e
i e
1
.g
, ~.,
s p
MUARKANSAS POWER & LIGHT COMPANY Fa i
C;? '
Arkansas Nuclear One WB N
RECORD'0F CHANGES AND REVISIONS OW NO.
i-s 1000.06A
..EME,RGENCY PLAN IMPLEMENTIIIG PROCEDURE
.% 'S REV. # 12 PC # -
Q:; 'M l Safety Related YES d NO O
'N '
DUTIES OF THE EMERGENCY MEDICAL TEAM
, J 1903.42 REV. 67
"'?-
- g[
fb h)j {}
{
PAGE REh'FC#
- ' Fads ARE ^ECYl' "'"PAGE' REE OPC#
PAGE REV PC#
PAGE REV PC#
1 6
2 6
3 6
4 6
5 6
~
J i
APPROVED BY:
APPROVAL DATE I
'Y
-O 6
- s. N a /l 4 J~,
REQUIRED' EFFECTIVE DATE:
(General Manager) g_
YNb.Y.?Y
$ $ $ Y Y h 5IYN I. g IMPLEMENTING PROC.
MEDICAL TEAM 1903.42 F #5 l PAGE 1 OI 3
-m ARKANSAS NUCLEAR ONE aevision
- oare v
- u' o '
CHANGE DATE 1.0 PURPOSE The purpose of this procedure is to provide guidance on the responsibili-ties and duties of the Emergency Medical Team for emergency situations.
2.0 SCOPE This procedure is applicable to personnel emergency situations involving Unit one and/or Unit Two.
3.0 REFERENCES
3.1 References Used in Procedure Preparation:
l 3.1.1 Emergency Plan 3.2 References Used in conjunction with this Procedure:
3.2.1 1903.10, " Emergency Action Level Response / Notifications" 3.2.2 1903.23, " Personnel Emergency" l
3.3 Related ANO Procedures:
3.3.1 1903.22, " Fire or Explosion" 3.3.2 1903.35, " Administration of Potassium Iodide" 3.3.3 1903.60, " Emergency Supplies and Equipment" 3.4 Regulatory correspondence containing NRC commitments which are imple-mented in this procedure include:
[
3.4.1 Letter OCAN108213, Appendix A, Item 1, Section 5.4 4.0 DEFINITIONS 4.1 Operational Support Center (OSc) - The ' ANO administration buildings -
~
ihe Emergency Medical Team assembly area should be the First Aid Room (Admin. Bldg. - 2nd floor) and the 2nd floor breakroom.
4.2 Medical Kits..- A compilation of first aid supplies located in the four following places:
(1) First Aid Room, (2) Fire Locker A (Unit 1 Turbine Building, Elev. 354', South end), (3) Fire Locker B (Unit 2 Turbine Building, Elev. 354', North End), and (4) Fire Locker C (Unit 1/2 Turbine Building, Elev. 386 ', Near the Control Roo as).
E M h'/d y App 3gTION:
DggpggpKggg.
NO:
f IMPLEMENTING PROC.
HEDICAL TEAM 1903.42 y
PAGE
- asvisiOu o*Ts "'/"
CHANGE DATE 5.0 RESPONSIBILITIES 5.1 Emergency Medical Team Leader 5.1.1 Responsible for coordinating emergency medical response efforts, as necessary, when he arrives on site in accor-dance with procedure 1903.23, " Personnel Emergency".
5.1.2 Responsible for responding to Emergency Classes as de-scribed in this procedure.
5.1.3 Responsible for the initial and continued accountability
'of team personnel.
5.1.4 Responsible for performing quarterly phone number verifi-cations of team members per Form 1903.04B (to be provided by Emergency Planning Coordinators).
5.2 Emergency Medical Alternate Team Leader 5.2.1 Responsible for assisting in coordinating emergency medical response efforts.
5.2.2 Responsible for assuming the responsibilities of the Emer-gency Medical Team Leader if the designated Team Leader is j
not available to respond.
I' 5.3 Emergency Medical Team 5.3.1 Responsible for providing emergency first aid to injured j
persons per the directions of the Emergency Medical Team Leader.
5.3.2 Responsible for performing, in conjunction with the Emer-gency Radiation Team, decontamination and onsite rescue operations per the directions of the Emergency Medical Team Leader.
5.3.3 Responsible for responding Jo Emergency Classes as de-scribed in this procedure.
I l.
NOTE:
l
[
l The first Emergency Medical Team member at the l
I scene of a medical, emergency shall assume the l
I duties of the Emergency Medical Team Leader l
l until relieved by the designated team leader I
l or alternate.
{
5.4 Shift Medical Personnel 5.4.1 Responsible for assuming the responsibilities of the Emer-gency Medical Team durir.g non-rcutine work hours.
l g
ggpfg ON:
ggygggDgy7ggg j N2 E
j j
IMPLEMENTING PROC.
'!EDICAL TEAM 1903.42 y#
i PAGE 4
55 mm ARKANSAS NUCLEAR ONE aavision o^ra v""*
CHANGE DATE 5.4.2 Responsible for responding to medical emergencies during routine work hours only when specifically requested to do 6.0 NOTIFICATIONS 6.1 During routine work hours, the Emergency Medical Team personnel on site should be contacted either by telephone or the plant paging system.
6.2 After routine work hours, the shift medical personnel may be contacted by the most expedient means available, (i.e. the plant paging system or ext. 3142/3411). In the event that additional support is needed by the shift medical personnel, the Emergency Medical Team may be con-tacted as follows:
6.2.1 Refer to the Emergency Telephone Directory.
6.2.2 Contact a Team Leader / Alternate Team Leader.
6.2.3 Provide the individual contacted with appropriate informa-tion and request them to ensure that contact is attempted with the remaining team personnel, as needed.
6.3 The following information shculd be provided to the notified Emergency Medical Team personnel as indicated:
6.3.1 If team personnel are to respond to a medical emergency that does not involve an Emergency Action Level, they should be provided with the location and type of the medical emergency, as known.
6.3.2 If team personnel are to respond to an Emergency Class that may or may not involve a medical emergency, they should be provided the following information, as known:
A.
Affected unit.
B.
Emergency Class declarsd.
C.
Immediate response required.
D.
Other information, as the situation dictates.
i I
fMil51M&^Mf9MN:
36ME5DB98WWitbWi IMPLEMENTING PROC.
4EDICAL TEAM 1903.42 PAGE
CHANGE DATE 7.0 MEDICAL RESPONSE INSTRUCTIONS 7.1 If an immediate response is required, the Emergency Medical Team should take the following actions:
l NOTE:
l l Emergency hand-held radios may be obtained from the Key l
l Room (Turbine Bldg., Elevation 386') or the Main Guard l
l Station upon request.
l 7.1.1 Equipment should be obtained from the appropriate medical kit, if necessary.
7.1.2 Medical Team personnel should then respond to the scene of the emergency, unless otherwise instructed.
l NOTE:
l l If necessary, directions to the scene of the l
l emergency (or an escort) may be obtained from I
i the appropriate control room (preferably contact l
l the Control Room which was responsible for making l l the emergency announcement over the PA system).
l l
l.
l Unit 1 Control Room 3101, 3102 l
l Unit 2 Control Room 3201, 3202 l
7.1.3 The Emergency Medical Team should respond to emergencies in accordance with procedure 1903.23, " Personnel Emergency".
7.1.4 The team leader should provide an assessment of the situa-l tion to the Shift Operations Supervisor / Duty Emergency
{
Coordinator.
7.1.5 After the initial team response, the Emergency Medical Team j
should report as directed by the Shift Operations Supgrvisor/
Duty Emergency Coordinator.
8.0 EMERGENCY ACTION LEVEL (EAL) RESPONSE GUIDELINES J
8.1 Notification of Unusual Event No action is~ required by the Emergency Medical Team unless the Notification of Unusual Event is declared as a result of a medical emergency. In that case, refer to Section 7.0 of this procedure.
8.2 Alert If the energency situation does not involve a medical emergency, the Emergency Medical Team personnel shall be placed en a " standby status" as long as the Alert Emergency Class declaration is in effect.
o o
s e
{ggggjg ON:
JygggDggggg NQ j j IMPLEMENTING PROC.
1EDICAL TEAM 1903.42 F l' PAGE 3 UN 3 M
ARKANSAS NUCLEAR ONE aavision o^ra ' " " '
- CHANGE DATE 8.2.1 Notifications should be made in accordance with Section 6.0 of this procedure.
8.2.2 When onsite, the team leader should report to the Duty Emergency Coordinator to obtain further instructions, as necessary.
8.3 Site Area Emergency / General Emergency i
l NOTE:
l l The transition from an Alert to a Site Area / General Emer-l l gency activates the long-term Emergency Response Organi-1 I
l zation. Upon arrival on-site and an appropriate turnover i f
I from the Duty Emergency Coordinator, the Administrative 1
l Manager will coordinate the actions of the onsite medical l I response personnel.
1 If the emergency situation does not involve a medical emergency. the Emergency Medical Team personnel shall report to the First Aid Room /
Break Room Area (2nd floor - Admin. Bldg.) unless otherwise directed.
The Team Leader shall expeditiously account for the tea.
ers and report the results to the Technical Support Center a giving the names and badge numbers of all accounted for team members.
The team shall then await further instructions.
9.0 ATTACHMENTS AND FORMS None
\\
The information contained within the symbols (*) is proprietary or private infor-mation.
0
'R E GlJL A TUR Y INFOR**ATION DISTRIBUTION SYSTEM (RIOS)
ACCESSION NFR:8 N 00C.DATL: 8t4/08/15 tJOT AP! ZED: H0 DOCKET a FACIL 50-343 Arkansas Nuclear One, tinit 1,
Arkansas Poaer s Ligat 05000313 50-308 Arkansas.4uclear One, Unit 2, Arkansas Power & Lisht d50003oe AUTH.NAME AUTHus AFFILIATIeN LEVINE,J.M.
Arkansas Power & Light Co.
RECIP.NAME RECIPItNT AFFILIATION SUOJECT: Central Files version of revised Emergency Plan Implementing Proceaures 1903.33, " Administration of Potassium Iodine" a 1903.42, "Outies of Emeroency t'edical Team." w/840817 transmittal memo.
DISTRIBUTION CODE: X 0 0 '.2 S COPILS RtCEivED LTH O_ ENCL _
SIZF:__h,_____
U TITLE: Emero Plan (CF Avail)
NOTES:AEOD/Ornstein:1cy.
05000313 OL:05/21/74 usu00366 OL: 07/18/78 HECIPIENT COPIES RECIPIEi4T C u r' T E 9 IJ CODE /NAMC tTTR ENCL 10 CODE /NAbE LTTP ENCL NRn OR oI4 BC 0
NRo OR&3 dC 0
VISSING,G 01 1
LdE,A.S.
01 1
IN TERN ALCA0i / orc 3 32 1
FEMA TECH 4 AZO 9 L
1
,IE/0EPER/EP9 03 2
IE/DEPER/IDb t
I hPH/OSI/aEo 1
NRR/DSI/ RAS 1
0 REG FILE 3 01 1
i NOTES 8 1
s J
OA o
3 n.m
,e te m Ne m e.
1e m e1.LO u1 a
-*/
I
[lg nea o,[.., '
UNITED STATES
,d
-g WASHINGTON, D. C. 20555 NUCLEAR REGULATORY COMMISSION D
t 04,
,/
September 14, 1984 50-313/368 Arkansas Nuclear One MEMORANDUM FOR: Chief, Document Management Branch, TIDC FROM:
Director, Division of Rules and Records, ADM
SUBJECT:
REVIEW 0F UTILITY EMERGENCY PLAN DOCUMENTATION The Division of Rules and Records has reviewed the attached document and has determined that it may now be made publici available.
f./ / ~
.'M.
Felton, Director division of Rules and Record ~ ' [
Office of Administration
/
Attachment:
As stated J
e